Headaches in multiple sclerosis patients might imply an inflammatorial process.

by Jan Möhrke, Peter Kropp, Uwe K Zettl
Published 2013-01-01

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review

by Mazen Abu-Mugheisib, Reiner Benecke, Uwe K. Zettl
Published 2011-01-01

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

by Hela-Felicitas Petereit, Hayrettin Tumani, Uwe K. Zettl
Published 2021-06-01

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis

by Uwe K. Zettl, Paulus Rommer, Petra Hipp, Robert Patejdl
Published 2016-01-01

Vaccination in Multiple Sclerosis: Friend or Foe?

by Tobias Zrzavy, Herwig Kollaritsch, Paulus S. Rommer, Paulus S. Rommer, Nina Boxberger, Micha Loebermann, Isabella Wimmer, Alexander Winkelmann, Uwe K. Zettl, Uwe K. Zettl
Published 2019-08-01

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients

by Paulus S. Rommer, Martin S. Weber, Martin S. Weber, Zsolt Illes, Zsolt Illes, Uwe K. Zettl
Published 2020-02-01

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19

by Marc Pawlitzki, Uwe K. Zettl, Tobias Ruck, Leoni Rolfes, Hans-Peter Hartung, Sven G. Meuth
Published 2020-06-01

The Cerebrospinal Fluid in Multiple Sclerosis

by Florian Deisenhammer, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Brit Fitzner, Uwe K. Zettl
Published 2019-04-01

Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.

by Johannes Ehler, Sebastian Koball, Martin Sauer, Steffen Mitzner, Heiko Hickstein, Reiner Benecke, Uwe K Zettl
Published 2015-01-01

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.

by Ahmed Abdelhak, Tilman Hottenrott, Christoph Mayer, Gudrun Hintereder, Uwe K Zettl, Oliver Stich, Hayrettin Tumani
Published 2017-01-01

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing m...

by Peter Rieckmann, Fedor Heidenreich, Michael Sailer, Uwe K. Zettl, Norbert Zessack, Hans-Peter Hartung, Ralf Gold
Published 2012-01-01

Cerebrospinal fluid biomarkers in multiple sclerosis

by Hayrettin Tumani, Hans-Peter Hartung, Bernhard Hemmer, Charlotte Teunissen, Florian Deisenhammer, Gavin Giovannoni, Uwe K. Zettl
Published 2009-08-01

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients

by Paulus S. Rommer, Paulus S. Rommer, Klaus Berger, David Ellenberger, Firas Fneish, Alexandra Simbrich, Alexander Stahmann, Uwe K. Zettl
Published 2020-09-01

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate...

by Johannes Ehler, Stephan Blechinger, Paulus S. Rommer, Sebastian Koball, Steffen Mitzner, Hans-Peter Hartung, Fritz Leutmezer, Martin Sauer, Uwe K. Zettl
Published 2017-08-01

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis

by Tilman Robinson, Ahmed Abdelhak, Tanima Bose, Edgar Meinl, Markus Otto, Uwe K. Zettl, Rick Dersch, Hayrettin Tumani, Sebastian Rauer, André Huss
Published 2020-11-01

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

by Ralf Gold, Gerd Fätkenheuer, Hans-Peter Hartung, Christoph Kleinschnitz, Reinhard Marks, Matthias Maschke, Antonios Bayas, Micha Löbermann, Uwe K. Zettl, Heinz Wiendl
Published 2021-07-01

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis

by Niklas Frahm, Melanie Peters, Jörg Bätzing, David Ellenberger, Manas K. Akmatov, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl, Jakob Holstiege
Published 2021-10-01

Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers

by Oliver Neuhaus, Wolfgang Köhler, Florian Then Bergh, Wolfgang Kristoferitsch, Jürgen Faiss, Thorsten Rosenkranz, Dirk Reske, Robert Patejdl, Hans-Peter Hartung, Uwe K. Zettl
Published 2021-03-01

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

by Lisa-Marie Ohle, David Ellenberger, Peter Flachenecker, Tim Friede, Judith Haas, Kerstin Hellwig, Tina Parciak, Clemens Warnke, Friedemann Paul, Uwe K. Zettl, Alexander Stahmann
Published 2021-06-01

Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices

by Michael Walz, Christine Höflich, Christina Walz, Daniela Ohde, Julia Brenmoehl, Mandy Sawitzky, Andreas Vernunft, Uwe K. Zettl, Susanne Holtze, Thomas B. Hildebrandt, Eckhard Wolf, Andreas Hoeflich
Published 2021-02-01